Medigus: Eventer Technologies Ltd. Submitted Confidential Draft Registration Statement for the Proposed U.S. Initial Public Offering

Rhea-AI Summary

Medigus Ltd. (Nasdaq: MDGS) announced that its 47.69% owned subsidiary, Eventer Technologies Ltd., submitted a draft registration statement on Form F-1 to the SEC for a potential IPO of its shares in the U.S. Eventer specializes in cloud-based ticketing solutions for various events, including in-person, virtual, and hybrid formats. The specific timing, number of shares, and pricing for the offering remain undetermined. This initiative aims to leverage Eventer's innovative technology platform to enhance shareholder value.

Positive

• Eventer Technologies is seeking an IPO, indicating potential growth opportunities.
• Cloud-based ticketing solutions cater to diverse event types, enhancing market reach.

Negative

• The timing and pricing of the IPO are not yet determined, creating uncertainty.
• Potential dilution of shares if existing shareholders are not prioritized in the offering.

Tel Aviv, Israel, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced that its 47.69% owned subsidiary, Eventer Technologies Ltd. ( “Eventer”), software company engaged in the development and operation of a technology platform, based on cloud computing, for the management of ticketing sales for in-person, virtual (events which occur and are broadcast over a digital platform over the internet), and hybrid events (events that allow both in-person and virtual participation) of various types, including performances, festivals, courses, lectures, conferences and different activities, confidentially submitted a draft registration statement on Form F-1 to the U.S. Securities and Exchange Commission (the “SEC”) relating to a potential initial public offering of its ordinary shares in the United States. The timing, number of ordinary shares to be offered and the price range for the proposed offering have not yet been determined.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

About Medigus

Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce and electric vehicle markets. Medigus’ affiliations in the medical solutions arena include ownership in Polyzion Ltd and ownership in industry 4.0 company, ScoutCam Inc. The Company’s affiliates in digital commerce include Gix Internet Ltd., Jeffs’ Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics Ltd. and Revoltz Ltd. are also part of the Company’s portfolio of technology solution providers. To learn more about Medigus’ advanced technologies, please visit http://www.medigus.com/.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Medigus uses forward-looking statements in this press release when it discusses the potential initial public offering of Eventer. Because such statements deal with future events and are based on Medigus’ current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements of Medigus could differ materially from those described in or implied by the statements in this press release.

The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Medigus undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Medigus is not responsible for the contents of third-party website

Company Contact:

Tali Dinar
Chief Financial Officer
+972-8-6466-880
ir@medigus.com

Investor Relations Contact:

Miri Segal
CEO
MS-IR LLC
+1-917-607-8654
msegal@ms-ir.com

FAQ

What is the potential IPO of Eventer Technologies Ltd. associated with Medigus (MDGS)?

Eventer Technologies Ltd., a subsidiary of Medigus, has submitted a draft registration statement for a potential IPO to the SEC.

What are the key details regarding the IPO submission by Eventer?

The submission is for an IPO of ordinary shares; however, the timing, number of shares, and price range have not yet been determined.

How could the IPO of Eventer Technologies impact Medigus (MDGS) shareholders?

The IPO could raise funds for Eventer, potentially enhancing shareholder value, although it may also lead to dilution.

What technology does Eventer Technologies focus on that supports its IPO?

Eventer Technologies specializes in cloud-based ticketing solutions for managing in-person, virtual, and hybrid events.